Curis, Inc. (NASDAQ: CRIS) – brief chart analysis for you – lots of room to grow Play on your own risk. About Curis, Inc. Curis, Inc., (NASDAQ: CRIS) a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. The company develops CUDC-907, […]
Chart/Volume Play – be sure that you read Curis’s PR beforehands: Curis, Inc. (CRIS), a biotechnology company, announced on September 14th, 2014 the pricing of an underwritten public offering of 20,000,000 shares of its common stock (the “Offering”). The Offering is expected to close on or about September 18, 2017, subject to customary closing conditions. […]
Trading opportunity – RTTR– don’t miss it. As usual – risky hence play it with guts. Shares Outstanding 11.62M Float 7.5M % Held by Insiders 30.71% % Held by Institutions 25.80% Shares Short 564920 (source – yahoo finance) Ritter Pharmaceuticals Announces Lactose Intolerance Treatment, RP-G28, Demonstrated Efficacy and Clinically Meaningful Benefit in Phase 2b/3 Clinical […]
AREX – heavily shorted, earnings are coming (is anyone with a little Martha Stewart info leak around?), dilutive filings: FORT WORTH, Texas, Jan. 30, 2017 (GLOBE NEWSWIRE) — Approach Resources Inc. (AREX) (“Approach” or the “Company”) today announced the commencement of an offer (“Exchange Offer”) to exchange newly issued shares of its common stock, par […]
We are rarely re-posting articles but… no way to say better that Pros do: Silimed: Particles and Polymers – Professor J D Frame, Dr M Olivan The recent release of censured but commercially sensitive information on particle surface contamination of silicone implants via the Silimed information centre , the MHRA (Medicines and Healthcare Regulatory Agency), […]
Congratulations to everyone who’s followed our alert on SIEN Up to 15% in a matter of a few days – can you find a better trade from an entire Nasdaq? SIEN – we re-enter into at mid-day on Friday for a “hold” for a month or a few. Good reading: Sientra sends letter to surgeons […]
Sientra Inc. expected to be the queen of the breast-implant industry when it entered the U.S. market in 2012 with set of new shapes and textures – so much for women to choose from. Said so, the company was supplying about 9-10 percent of implants in the U.S., a.k.a. took roughly $30 million of $300 million […]
Rare Element Resources (REE) shares gained 20.86% on Friday’s trading session closed a few cents off of its monthly resistance within 4X 3month volume average: Classical chart setup, isn’t it? Rare Element Resources Ltd. is a mineral resource company focused on exploration and development of rare earth deposits, specifically those with significant distribution of critical […]
IFON announced on December 19, 2013 that it received a letter from the Nasdaq Listing Qualifications Staff (the “Staff”) advising that the Staff had determined that: The Company had not regained compliance with the $1.00 per share minimum bid price requirement of Nasdaq Listing Rule 5550(a)(2) as of December 9, 2013 Unless InfoSonics requested an […]
GlassesOff (GLSO) could revolutionize how presbyopia is treated, all for 15 minutes a day, 3 days a week, for 2 – 3 months at most. Decades of research into neuroplasticity underlie a robust program that is developed as a ‘game’ that ‘trains’ your brain to better process near objects and images. GLSO recently announced the […]
